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Summary The expression of nm23-H1 mRNA and protein was studied in colorectal cancers by Northern
blotting and immunohistochemistry. All 21 colorectal cancers studied by Northern blotting had increased
levels of nm23-HI mRNA relative to the adjacent normal colonic mucosa. Increased nm23-HI protein
expression was also observed in all 36 colorectal cancer cases including those studied by Northern blotting.
There was no significant correlation between nm23-HI expression and tumour histology, serosal invasion,
lymphatic invasion, venous invasion, or lymph node metastasis. However, the expression of both mRNA and
protein was significantly lower in tumours associated with liver metastasis than in those without such
metastasis. These observations indicate that the nm23 gene may play a role in the suppression of liver
metastasis of colorectal cancer.
The nm23 gene was originally identified by differential
hybridisation between two murine melanoma cell sublines
with low and high metastatic potential (Steeg et al., 1988a).
Subsequently, a high degree of sequence homology has been
reported between nm23 and nucleoside diphosphate (NDP)
kinase in several specieis, including humans, rats, insects and
bacteria (Biggs et al., 1988; Kimura et al., 1990; Munioz-
Dorado et al., 1990; Lacombe et al., 1990; Stahl et al., 1991;
Hama et al., 1991; Urano et al., 1992). NDP kinase activity
of nm23 protein has also been reported, indicating the iden-
tity of these two molecules (Urano et al., 1992a,b).
A suppressor function of the nm23/NDP kinase molecule
has been suggested by several rodent tumours that feature
reduced expression of this gene in highly metastatic cell lines
when compared to weakly metastatic sublines. These include
a murine melanoma (Steeg et al., 1988a), N-nitroso-N-
methylurea-induced rat mammary carcinoma (Steeg et al.,
1988a), and oncogene-transformed rat embryonic fibroblasts
(Steeg et al., 1988b). More direct evidence was provided by
Leone et al. (1991), who showed that transfection of the
nm23 gene into a highly metastatic murine melanoma cell line
resulted in a change of its metastatic potential.
In addition to these findings in experimental tumours, a
relationship has been reported between the expression of
nm23-H1, an isotype of the human nm23/NDP kinase gene,
and the prognosis of human breast cancer. Breast cancer
patients whose tumours showed reduced nm23-HI expression
had a higher rate of lymph node metastasis, which may have
reduced their survival (Bevilacqua et al., 1989; Hennessy et
al., 1991; Barnes et al., 1991; Hirayama et al., 1991). How-
ever, Haut et al. (1991) failed to observe a similar association
in human colonic neoplasms. They found increased expres-
sion of nm23-H1 mRNA in 16/18 colon cancers when com-
pared to the adjacent normal mucosa. Lacombe et al. (1991)
also reported similar findings in several different human solid
tumours, although the number of cases studied was rather
limited. In contrast, Cohn et al. (1991) reported that 8/11
(73%) patients with colorectal cancers that showed nm23-H1
allelic deletion developed distant metastasis, while only 2/10
(20%) patients without nm23-H1 deletion developed distant
metastasis. They suggested that nm23-H 1 may be a late-
acting suppressor gene for colorectal cancer or may be
located near such a gene.
These rather controversial observations on colorectal
cancer prompted us to investigate nm23-HI gene expression
at the mRNA level as well as the protein level in this type of
cancer. Elevated expression of the nm23-HI gene was found
in all colorectal cancer samples compared to the adjacent
normal mucosa. No significant correlation was observed
between nm23-H1 expression and tumour histology, serosal
invasion, lymphatic invasion, venous invasion, or lymph
node metastasis. However, a significant decrease in nm23-H1
gene expression was noted in tumours associated with liver
metastasis when compared to those without.
Materials and methods
Patients and tissue samples
Specimens of 36 colorectal cancers and the adjacent normal
mucosa were obtained from patients operated at the Second
Department of Surgery, Kanazawa University School of
Medicine, between 1989 and 1992. They included 21 patients
with colon cancer and 15 with rectal cancer. Lymph node
metastases were present in 23 patients (63.9%). Liver metas-
tasis was found in nine patients (25.0%), including one
whose liver was free of metastasis at the time of operation,
and subsequently became metastasis positive. Metastasis did
not develop in any other cases by October, 1992.
Northern blot analysis
Each resected specimen was immediately frozen in liquid
nitrogen. Total RNA was prepared by acid guanidinium
thiocyanate-phenol-chloroform extraction (Chomczynski &
Sacchi, 1987). Twenty micrograms of isolated RNA was
electrophoretically separated on 1% agarose gel containing
formaldehyde and transferred to a nylon membrane (Gene-
Screen plus, Du Pont). Hybridisation and stringent washing
were performed according to the manufacturer's directions.
Probes were labelled with [a-32P]dCTP using a multiprime
labelling kit (Amersham). For hybridisation studies, the
BamHI-EcoRI fragment of pBSK-H1 was used as the probe
(Urano et al., 1992a). The radioactivity was determined using
a BAS2000 bioimaging and analyser (Fuji). Levels of expres-
sion of the P-actin were employed as an internal standard to
correct the compared samples for variations in the amount of
messenger RNA loaded.
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Immunoblotting
Nonidet P-40 lysates containing 15 itg protein separated on
15% SDS-PAGE were electrophoretically transferred on to
an Immobilon membrane (Millipore). nm23-HI protein was
detected using a specific monoclonal antibody (mAb) directed
against this protein (mAb HI-229, 1 pg ml1'). The details of
mAb HI-229 specific for nm23-H1 protein are, described
elsewhere (Urano et al., 1993; Tokunaga et al., 1993).
Immunodetection was performed using an Enhanced Chemi-
luminescence Detection System (Amersham). The membrane
was exposed to XAR-5 film (Kodak) for 30 s at room
temperature. The protein concentration in the extracted sam-
ples were determined basically according to the Lowry
method (Lowry et al., 1951) except that SDS was added to
eliminate the influence of NP-40.
nm23-H1
-0.8 Kb
Immunohistochemistry
Tissue samples were fixed by the acetone, methyl benzoate,
and xylene (AMeX) method (Sato et al., 1986), embedded in
paraffin, and cut into 41 m sections. The sections were de-
waxed, and endogenous peroxidase activity was blocked by
incubation with 1% hydrogen peroxide in methanol for
30 min. The sections were then preincubated with normal
goat serum for 15 min to reduce non-specific staining, and
incubated with mAb HI -229 (1 isg ml-') at room tempera-
ture for 3 h. Next, the sections were washed with Tris
buffered-saline (TBS) and incubated with biotinylated goat
anti-mouse immunoglobulin G (Dakopatts) at room temper-
ature for 30min. After another wash with TBS, they were
covered with a 1:100 dilution of streptoavidin-biotin-peroxi-
dase complex (Dakopatts). The antibody was visualised by
reaction with 3-3'-diaminobenzene tetrahydrochloride (Do-
tide, Tokyo, Japan) and H202 in 0.5 mM Tris buffer (pH 7.2).
Slides were lightly counterstained with hematoxylin. Negative
control studies were carried out by omitting the primary
antibody to nm23-H1 (mAb HI-229). In each experiment,
samples of normal colon, breast and liver were routinely
included for standardisation of immunostaining. Normal
colon was consistently either negatively or very faintly
stained whereas normal breast and liver were strongly
stained.
Statistical analysis
Data are presented as the mean ± standard deviation. Statis-
tical analysis was performed by the x2 or Student's t-test.
Differences were taken as significant when P was less than
0.05.
Results
Increased expression ofnm23-HJ mRNA andproteins in
colorectal cancer
Northern blot hybridisation detected a 0.8 kb mRNA that
corresponded to transcripts of nm23-H1 in specimens of both
colorectal cancer and normal mucosa. The expression of
nm23-HI by the colorectal cancers exceeded that of the adja-
cent normal colonic mucosa in all 21 patients for whom we
analysed paired tissue samples, even after correction with
P-actin as the internal control. A representative example is
shown in Figure 1. The expression of nm23-H1 protein in
colorectal cancers and the adjacent normal mucosa was also
analysed by immunoblotting using mAb HI-229, which is
specific for human nm23-Hl protein. A representative exam-
ple is shown in Figure 2. Prominent 20.5 kDa bands (as
expected for nm23-H protein) were observed when the colo-
rectal cancer extracts were tested, whereas far weaker bands
were detected when the extracts from normal colonic mucosa
were assayed. In all cases examined, nm23-HI protein show-
ed more prominent expression in the cancer tissue than in the
adjacent normal colonic mucosa, a result compatible with the
findings of Northern blot analysis.
1-actin
Figure 1 Northern blot analysis of nm23-Hl expression utilising
total RNA from colorectal cancers (T) and the adjacent normal
colonic mucosa (N). nm23-H RNA expression by the colorectal
cancers exceeded that of the adjacent normal mucosa in all three
cases.
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Figure 2 Immunoblotting of tissue extracts of colorectal cancers
(T) and the adjacent normal colonic mucosa (N) using a mono-
clonal antibody (HI-229) specific for nm23-H1 protein. The
arrow indicates the band of nm23-Hl protein at 20.5 kDa.
Reduced expression ofnm23-HJ mRNA in tumours with liver
metastasis
The relationship between the level of nm23-HI mRNA ex-
pression, as determined from the ratio of nm23-HI tran-
scripts in cancer tissue to that in the adjacent normal
mucosa, and lymph node metastasis was analysed next. The
average nm23-H ratio was 2.70 1.06 for lesions without
lymph node metastasis and 2.05 0.96 for those associated
with metastasis (Figure 3), and there was no significant
difference between the two groups. However, the average
nm23-H1 expression ratio was significantly lower for lesions
associated with liver metastasis than for those without such
metastasis being 2.45 ± 1.02 vs 1.55 ± 0.63, respectively
(P<0.05) (Figure 4).
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Figure 3 The relationship between nm23-HI expression and
lymph node metastasis. There was no significant correlation
between metastasis and the ratio of nm23-H1 transcripts in
cancer tissues to that in the adjacent normal mucosa.
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grade 2, and 15 (41.7%) as grade 3. In 21 cases where both
Northern blotting and immunohistochemistry were perform-
ed, the relationship between nm23-H1 mRNA expression and
immunoreactivity for the nm23-Hl protein was compared.
The average ratio of nm23-H1 RNA expression was 1.26 ±
0.28 for grade 1 tumours, 1.94 ± 1.21 for grade 2 and
2.57 ± 0.83 for grade 3. nm23-Hl RNA expression in grade 1
tumours was significantly lower than in grade 3.
Reduced expression ofnm23-HJ protein in tumours with liver
metastasis by immunohistochemistry
All 36 colorectal cancers were examined to determine the
relationship between histological findings and immunore-
activity for nm23-H1 protein. There was no significant cor-
relation between nm23-H1 immunoreactivity and tumour
histology, serosal invasion, lymphatic invasion, or venous
invasion (Table I). In comparison of nm23 expression with
histological types of cancers, six of seven well differentiated
and 22 of 24 moderately differentiated tumours were classi-
fied as grade 2 or 3 while only three of five with the poorly
differentiated tumours were poorly stained (grade 1), which
may indicate some relationship between differentiation pat-
tern and nm23 expression. This however needs further study
with more samples of poorly differentiated type.
Lymph node metastasis was positive in 3/5 (60%) grade 1
tumours, 9/16 (56.3%) grade 2 and 11/15 (73.3%) grade 3, so
there was no association between nm23-HI immunoreactivity
and the frequency of lymph node metastasis (Table II).
The relationship between nm23-HI immunoreactivity and
liver metastasis was also examined. Liver metastasis was
positive in 2/5 (40.0%) grade I tumours, 6/16 (37.5%) grade
2 and 1/15 (6.7%) in grade 3. The rate of liver metastasis was
significantly lower for grades 2 and 3 tumours than for
tumours of grade I (Table III).
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Figure 4 The relationship between nm23-Hl expression and liver
metastasis. nm23-H I RNA levels were significantly lower in
tumours with liver metastasis than in those without it.
Immunohistochemical analysis ofcolorectal cancers using mAb
HI-229
Twenty-five samples of adjacent normal colonic mucosa
showed only a low intensity of staining by mAb Hi-229,
while much stronger staining was observed to a varying
degree in the cancer tissues (Figure 5). Positive staining was
most often observed in the cytoplasm of tumour cells, but a
few tumours showed positive staining of the cell membrane.
The intensity of tumour staining with mAb HI-229 was
classified into the following three grades: grade 1, weak
staining of tumour cells; grade 2, moderate staining; and
grade 3, strong staining. Under this scoring condition, nor-
mal colon was consistently either negative or at most grade 1,
whereas normal breast and liver were grade 3. All of these
normal tissues were included in each experiment as described
in Materials and methods. Among the 36 colorectal cancers,
five lesions (13.9%) were classified as grade 1, 16 (44.4%) as
In agreement with the findings of lHaut et al. (1991), the
expression of nm23-H1 mRNA was noted in normal colonic
mucosal tissue. Additionally, in all the colorectal cancer tis-
sues we examined, nm23-H1 mRNA expression was higher
than in the adjacent normal mucosa. This finding was also
confirmed at the protein level by immunoblotting with Hl-
229, a specific mAb for nm23-H1. Immunohistochemistry
using the same mAb revealed only relatively faint or border-
line staining of the normal mucosa, while more intense
(although somewhat variable) staining was observed in all
colorectal cancer tissues. This was compatible with the find-
ings regarding mRNA expression as well as with the protein
expression shown by immunoblotting. The mechanisms caus-
ing enhanced nm23-H1 expression in colorectal cancer are
unknown. Activation of the nm23-H1 gene might be a prere-
quisite for oncogenesis in this type of tumour, while an
alternate possibility is the modification of cellular characteris-
tics in relation to proliferation and/or differentiation as a
consequence of oncogenesis. Hailat et al. (1991), Lacombe et
al. (1991), and Sastre-Garau et al. (1992) have raised the
possibility that overexpression of nm23-H1 might be related
to the overproliferation of malignant cells. In fact, Keim et
al. (1992) very recently reported that peripheral blood lym-
phocytes stimulated with PHA showed a high level of nm23-
H1 protein expression, possibly in accordance with the per-
centage of S phase cells. However, it seems unlike'ly that
enhanced expression of the nm23-H1 gene in colorectal
cancers was due to an increase in S phase cells, because
virtually all the cancer cells were diffusely stained in each
tissue sample we tested and S phase cells are unlikely to
exceed 25% of the whole tumour cell population.
We have recently observed that a rapid decrease of nm23-
H1 expression occurs soon after the initiation of different-
iation induction in several human hematopoietic cell lines of
the myeloid, erythroid, and megakaryocyte lineages (unpub-
lished results). In addition, Okabe-Kado et al. (1992) have
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Figure 5 Immunoperoxidase staining of normal colonic mucosa and a well differentiated adenocarcinoma of the colon using
monoclonal antibody HI -229. The adjacent normal colonic mucosa showed a low intensity of staining, whereas the tumour cells
showed moderate cytoplasmic staining.
Table I Lack of a correlation between the nm23-H1 immuno-
reactivity as shown by immunohistochemistry and the clinicopatho-
logical findings of colorectal cancers
nm23-HJ immunoreactivity
Clinicopathological findings Gradea 1 2 3
Histological type
well differentiated 1 2 4
moderately differentiated 2 13 9
poorly differentiated 2 1 2
Serosal invasion
negative 2 11 13
positive 3 5 2
Lymphatic invasion
negative 0 2 4
positive 5 14 11
Venous invasion
negative 1 8 7
positive 4 8 8
'Grade 1, weakly stained; grade 2, moderately stained; grade 3,
strongly stained.
reported that I-factor, which is most likely identical with
nm23-M2 (a murine homologue of nm23-H2) (Urano et al.,
1992b), inhibits the differentiation of a murine myeloid leu-
kaemia cell line, M1. These findings are suggestive of an
inverse relationship between the numbers of nm23/NDP
kinase molecules and cellular differentiation, so the differ-
entiation of colorectal cancers may be linked to elevated
expression of the nm23-HI gene.
There was no significant correlation between the level of
expression of the nm23-HI gene and various clinicopatho-
logical parameters that we studied, including lymph node
metastasis. These findings were in contrast with several
Table II Lack of a correlation between nm23-H1 protein immuno-
reactivity as shown by immunohistochemistry and lymph node
metastasis
nm23-H1 No. of patients with lymph
immunoreactivity No. of patients node metastasis (%)
Grade ia 5 3 (60.0%)
Grade 2 16 9 (56.3%)
Grade 3 5 11 (73.3%)
aClassified as described in Table I.
Table III Correlation of nm23-H1 protein immunoreactivity as
shown by immunohistochemistry with liver metastasis
nm23-H1 No. of patients with liver
immunoreactivity No. of patients metastasis (%)
Grade Ia 5 2 (40.0%) b
Grade 2 16 6 (37.5%) 1
Grade 3 15 1 (6.7%)-
aClassified as described in Table I. bp<0.05 between grade 1 vs
grades 2 and 3.
analyses of human breast cancer in which an inverse correla-
tion was observed between nm23-H1 expression and lymph
node metastasis. We have also observed an inverse relation-
ship between nm23-HI expression and the rate of lymph
node metastasis in 130 breast cancer patients (Tokunaga et
al., 1993). We found that reduced expression of nm23-HI in
primary breast cancer might be a prognostic factor for this
disease independent of c-erbB-2 expression. In the current
study of colorectal cancers, the level ofnm23-H1 gene expres-
sion was relatively low in primary lesions with liver metas-
tasis, though not lower than in the adjacent normal mucosal
tissue. A similar finding was observed both at the mRNA1024 A. YAMAGUCHI et al.
level by Northern blotting and at the protein level by
immunohistochemistry. Haut et al. (1991) reported that in
colorectal cancer no inverse relation was found between
nm23 expression and metastatic potential. In their analysis
however, two out of three cases with distant metastasis also
show relatively low expression of nm23, which might be
compatible with our findings, though the number is small. A
probable antimetastatic function of the nm23-Hl gene in
human colorectal cancers was previously suggested by Cohn
et al. (1991) who observed allelic deletion of nm23-H1 in
tumours associated with distant metastasis. Their findings
may be in agreement with ours, although we could not
examine whether a low level of nm23-H1 expression was
accompanied by allelic deletion in this study. Analysis of
other larger cohorts ofcolorectal cancer is needed to examine
the wider applicability of our findings. Additionally, it is
essential to determine which functional properties of nm23/
NDP kinase are related to the suppression of metastasis in
human and rodent tumours.
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